Coronavirus: Vaccination

(asked on 7th March 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will request the Medicines and Healthcare Products Regulatory Agency to publish the interactive drug analysis profiles for each covid-19 vaccine.


Answered by
Maggie Throup Portrait
Maggie Throup
This question was answered on 21st March 2022

The Yellow Card scheme is the safety monitoring system operated by the Medicines and Healthcare products Regulatory Agency (MHRA). This scheme encourages reports of suspected adverse reactions from healthcare professionals, patients and the public for the purpose of detecting signals of new or changing safety issues. Data is used for the purpose of regulation and is held by the MHRA in confidence.

The MHRA publishes weekly summaries of Yellow Card data associated with the COVID-19 vaccines, including detailed analyses of safety signals to support understanding of the vaccine safety profiles. More specific and contextualised data from reports of suspected adverse reactions associated with COVID-19 vaccines such as the type of data included in interactive drug analysis profiles will be available by the end of 2022.

Reticulating Splines